Similar articles for PMID: 23278507

Year	Number of Results
1987	2
1988	2
1999	4
2000	2
2001	1
2002	4
2003	6
2004	7
2005	5
2006	4
2007	7
2008	7
2009	9
2010	5
2011	10
2012	15
2013	25
2014	31
2015	28
2016	20
2017	24
2018	16
2019	17
2020	16
2021	15
2022	10
2023	3
2024	0

1

Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice.

Lin B, Ha NB, Liu A, Trinh HN, Nguyen HA, Nguyen KK, Ahmed A, Keeffe EB, Garcia RT, Garcia G, Nguyen MH. Lin B, et al. J Gastroenterol Hepatol. 2013 May;28(5):855-60. doi: 10.1111/jgh.12108. J Gastroenterol Hepatol. 2013. PMID: 23278507

2

Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.

Reijnders JG, Perquin MJ, Zhang N, Hansen BE, Janssen HL. Reijnders JG, et al. Gastroenterology. 2010 Aug;139(2):491-8. doi: 10.1053/j.gastro.2010.03.059. Epub 2010 Apr 8. Gastroenterology. 2010. PMID: 20381492

3

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.

Leung NW, Lai CL, Chang TT, Guan R, Lee CM, Ng KY, Lim SG, Wu PC, Dent JC, Edmundson S, Condreay LD, Chien RN; Asia Hepatitis Lamivudine Study Group. Leung NW, et al. Hepatology. 2001 Jun;33(6):1527-32. doi: 10.1053/jhep.2001.25084. Hepatology. 2001. PMID: 11391543 Clinical Trial.

4

High frequency of recurrent viremia after hepatitis B e antigen seroconversion and consolidation therapy.

Chaung KT, Ha NB, Trinh HN, Garcia RT, Nguyen HA, Nguyen KK, Garcia G, Ahmed A, Keeffe EB, Nguyen MH. Chaung KT, et al. J Clin Gastroenterol. 2012 Nov-Dec;46(10):865-70. doi: 10.1097/MCG.0b013e31825ceed9. J Clin Gastroenterol. 2012. PMID: 22941429

5

Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.

Chan HL, Chan CK, Hui AJ, Chan S, Poordad F, Chang TT, Mathurin P, Flaherty JF, Lin L, Corsa A, Gaggar A, Subramanian GM, McHutchison JG, Lau G, Lee S, Gane EJ. Chan HL, et al. Gastroenterology. 2014 May;146(5):1240-8. doi: 10.1053/j.gastro.2014.01.044. Epub 2014 Jan 23. Gastroenterology. 2014. PMID: 24462735 Clinical Trial.

6

Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years.

Wong GL, Wong VW, Chan HY, Tse PC, Wong J, Chim AM, Yiu KK, Chu SH, Chan HL. Wong GL, et al. Aliment Pharmacol Ther. 2012 Jun;35(11):1326-35. doi: 10.1111/j.1365-2036.2012.05098.x. Epub 2012 Apr 16. Aliment Pharmacol Ther. 2012. PMID: 22506552 Free article.

7

Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients.

Buti M, Morillas RM, Prieto M, Diago M, Pérez J, Solà R, Bonet L, Palau A, Testillano M, García-Samaniego J, Rodríguez M; ORIENTE Study Group. Buti M, et al. Eur J Gastroenterol Hepatol. 2012 May;24(5):535-42. doi: 10.1097/MEG.0b013e3283511287. Eur J Gastroenterol Hepatol. 2012. PMID: 22382708

8

Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients.

Ono A, Suzuki F, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Suzuki Y, Saitou S, Arase Y, Ikeda K, Kobayashi M, Watahiki S, Mineta R, Kumada H. Ono A, et al. J Hepatol. 2012 Sep;57(3):508-14. doi: 10.1016/j.jhep.2012.04.037. Epub 2012 May 30. J Hepatol. 2012. PMID: 22659518

9

Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.

Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC. Sarin SK, et al. Am J Gastroenterol. 2005 Nov;100(11):2463-71. doi: 10.1111/j.1572-0241.2005.00247.x. Am J Gastroenterol. 2005. PMID: 16279901 Clinical Trial.

10

Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice.

Liu A, Ha NB, Lin B, Yip B, Trinh HN, Nguyen HA, Nguyen KK, Ahmed A, Garcia G, Nguyen MH. Liu A, et al. Eur J Gastroenterol Hepatol. 2013 Mar;25(3):338-43. doi: 10.1097/MEG.0b013e32835b3677. Eur J Gastroenterol Hepatol. 2013. PMID: 23169311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

263 results

Results by year